Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 28, 2026Current Organic Chemistry

An Insight into the Anti-Cancer Potential of N-Heterocyclic Compounds Targeting Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

K.Komal .RMRakhi MishraSVShruti Varshney

Discussion

Loading...

Member takes

Overview

This review explores N-heterocyclic compounds' anticancer effects in breast cancer, suggesting new therapeutic options.

Key Points

  • To investigate the therapeutic potential of N-heterocyclic compounds in breast cancer treatment.
  • Reviewed 66 studies from PubMed and Google Scholar
  • Analyzed interactions of compounds with molecular targets in breast cancer
  • Compared efficacy of N-heterocyclic compounds to standard treatments like doxorubicin
  • N-heterocyclic compounds show superior anticancer activity compared to standard drugs
  • Highlighted key molecular targets including estrogen receptors, HER2, and the PI3K/Akt/mTOR pathway
  • Clinical trials and patents confirm the anticancer potential of these compounds

Cite This Study

. et al. (2026) studied this question.

synapsesocial.com/papers/69a288060a974eb0d3c04044https://doi.org/10.2174/0113852728400723251121095338
View Full Paper
Ask AI
Bookmark
Share